[{"address1": "900 Middlefield Road", "address2": "4th Floor", "city": "Redwood City", "state": "CA", "zip": "94063", "country": "United States", "phone": "650 980 9099", "website": "https://biomeafusion.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Biomea Fusion, Inc., a clinical-stage diabetes and obesity medicines company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. It's lead product candidate is icovamenib, is designed to be a bioavailable, potent, and covalent inhibitor of menin, a ubiquitously expressed scaffold protein that functions in histone modification and epigenetic gene regulation to impact multiple cellular processes including cell cycle control, apoptosis, and DNA damage repair, it is used for the treatment of menin regulated or dependent diseases such as type 1 and type 2 diabetes. The company was incorporated in 2017 and is headquartered in Redwood City, California.", "fullTimeEmployees": 106, "companyOfficers": [{"maxAge": 1, "name": "Mr. Thomas Andrew Butler", "age": 43, "title": "Co-Founder & Chairman", "yearBorn": 1981, "fiscalYear": 2023, "totalPay": 950407, "exercisedValue": 0, "unexercisedValue": 5655125}, {"maxAge": 1, "name": "Dr. Michael J. M. Hitchcock Ph.D.", "age": 74, "title": "Interim CEO & Director", "yearBorn": 1950, "fiscalYear": 2023, "totalPay": 56500, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ramses M. Erdtmann", "age": 61, "title": "Co-Founder, President, COO & Director", "yearBorn": 1963, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Juan Pablo Frias M.D.", "title": "Chief Medical Officer", "fiscalYear": 2023, "totalPay": 492250, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Heow  Tan", "age": 65, "title": "Chief Technology & Quality Officer", "yearBorn": 1959, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Naomi  Cretcher", "title": "Chief People Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Thorsten  Kirschberg Ph.D.", "age": 54, "title": "Executive Vice President of Chemistry", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephan  Morris M.D.", "title": "Chief Development Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ravi  Upasani", "title": "Executive Vice President of Intellectual Property", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Caroline  Perez- Dupont", "title": "Senior Vice President of Contracts", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 10, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 10, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.73, "open": 1.74, "dayLow": 1.69, "dayHigh": 1.83, "regularMarketPreviousClose": 1.73, "regularMarketOpen": 1.74, "regularMarketDayLow": 1.69, "regularMarketDayHigh": 1.83, "payoutRatio": 0.0, "beta": -0.088, "forwardPE": -0.52710843, "volume": 396662, "regularMarketVolume": 396662, "averageVolume": 633998, "averageVolume10days": 853630, "averageDailyVolume10Day": 853630, "bid": 1.7, "ask": 1.79, "bidSize": 1, "askSize": 1, "marketCap": 65751524, "fiftyTwoWeekLow": 1.53, "fiftyTwoWeekHigh": 13.43, "fiftyDayAverage": 2.8633, "twoHundredDayAverage": 5.804475, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 30145170, "profitMargins": 0.0, "floatShares": 29397656, "sharesOutstanding": 37572200, "sharesShort": 10379166, "sharesShortPriorMonth": 11018925, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.2864, "heldPercentInsiders": 0.14812, "heldPercentInstitutions": 0.61282, "shortRatio": 17.38, "shortPercentOfFloat": 0.4664, "impliedSharesOutstanding": 37572300, "bookValue": 1.42, "priceToBook": 1.2323945, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -138426000, "trailingEps": -3.83, "forwardEps": -3.32, "enterpriseToEbitda": -0.212, "52WeekChange": -0.8601119, "SandP52WeekChange": 0.059571505, "quoteType": "EQUITY", "currentPrice": 1.75, "targetHighPrice": 54.0, "targetLowPrice": 3.0, "targetMeanPrice": 23.25, "targetMedianPrice": 19.0, "recommendationMean": 1.75, "recommendationKey": "buy", "numberOfAnalystOpinions": 8, "totalCash": 58279000, "totalCashPerShare": 1.551, "ebitda": -142322000, "totalDebt": 8771000, "quickRatio": 2.689, "currentRatio": 3.153, "debtToEquity": 17.007, "returnOnAssets": -0.64348, "returnOnEquity": -1.2537999, "freeCashflow": -78101752, "operatingCashflow": -119894000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "BMEA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Biomea Fusion, Inc.", "longName": "Biomea Fusion, Inc.", "fiftyTwoWeekHighChangePercent": -0.8696947, "fiftyTwoWeekChangePercent": -86.01119, "earningsTimestamp": 1743451800, "earningsTimestampStart": 1746216000, "earningsTimestampEnd": 1747425600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -3.83, "epsForward": -3.32, "epsCurrentYear": -2.6937, "priceEpsCurrentYear": -0.649664, "fiftyDayAverageChange": -1.1133001, "fiftyDayAverageChangePercent": -0.38881713, "twoHundredDayAverageChange": -4.054475, "twoHundredDayAverageChangePercent": -0.69850844, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-04-16", "averageAnalystRating": "1.8 - Buy", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1744402907, "regularMarketTime": 1744401601, "exchange": "NMS", "messageBoardId": "finmb_695310535", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 1.1560682, "regularMarketPrice": 1.75, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1618579800000, "postMarketChangePercent": 0.0, "postMarketPrice": 1.75, "postMarketChange": 0.0, "regularMarketChange": 0.01999998, "regularMarketDayRange": "1.69 - 1.83", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 633998, "fiftyTwoWeekLowChange": 0.22000003, "fiftyTwoWeekLowChangePercent": 0.14379087, "fiftyTwoWeekRange": "1.53 - 13.43", "fiftyTwoWeekHighChange": -11.68, "displayName": "Biomea Fusion", "trailingPegRatio": null, "__fetch_time": "2025-04-12"}]